Associate professor at the UA University of Pharmacy.

Snyder shall use UA College of Medication faculty users Cori Daines, MD, and Wayne Morgan, MD, on the task. Cystic fibrosis is normally a disease that impacts the lung. According to the Cystic Fibrosis Basis, about 30,000 children and adults in the usa have problems with CF. The disease results from a genetic alteration that lowers the function of chloride channels in the lung, that leads to a dried out lung. The drier a CF patient’s lungs, the more dangerous their disease. The fluctuations of sodium, potassium and chloride in the lung all are essential in keeping the lung wet and so are of particular importance in cystic fibrosis. Studies in the past using cell lines or animal tissues show that the administration of a common drug used in cystic fibrosis, a beta-agonist, increases the quantity of chloride on cells and this should help keep the lungs wet.In one pre-described subgroup to which patients were stratified, those who expressed the wild-type K-ras proto-oncogene and who experienced discontinued oxaliplatin for toxicity instead of for disease progression, there was an advantage in OS and in PFS for perifosine treated individuals. The reason for this finding is not clear at present and additional analysis, including biomarkers research, are ongoing. Juergen Engel, PhD, CEO and President at Aeterna Zentaris commented, ‘These data confirm the disappointing topline results disclosed in April.